menu
    • menu

    Company profile for Suzhou Forlong Biotechnology

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Forlong Biotechnology is a clinical-stage biotech company developing next-generation cytokine therapeutics through advanced synthetic immunology. With four core technology platforms, we aim to overcome the challenges in cytokine drug development and transform cancer treatment. Focused on tumor immunology, our engineered cytokine combinations target key stages of the cancer-immunity cycle. Our lead asset, FL115—an IL-15 super...
    Forlong Biotechnology is a clinical-stage biotech company developing next-generation cytokine therapeutics through advanced synthetic immunology. With four core technology platforms, we aim to overcome the challenges in cytokine drug development and transform cancer treatment. Focused on tumor immunology, our engineered cytokine combinations target key stages of the cancer-immunity cycle. Our lead asset, FL115—an IL-15 super agonist—has shown strong safety and efficacy in clinical trials, achieving partial response as a monotherapy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Suzhou Forlong BiotechnologyChina Flag
    Country
    Country
    China
    Address
    Address
    310, Building 1, No. 19 Yong 'an Road, Suzhou
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.forlongbiotech.com/en
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Forlong Bio To Unveil FL115 Clinical Data At 2026 ASCO Meeting
    Forlong Bio To Unveil FL115 Clinical Data At 2026 ASCO Meeting

    21 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-21/forlong-biotechnology-to-present-clinical-data-from-the-first-in-human-study-for-fl115-il-15-supera

    PHARMIWEB
    21 Apr 2026
    Share Share
    Forlong Prepares GMP Production For FL115 Trial In NMIBC Cancer
    Forlong Prepares GMP Production For FL115 Trial In NMIBC Cancer

    15 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-15/forlong-biotechnology-announced-cmc-readiness-to-initiate-gmp-batch-production-to-support-upcoming-p

    PHARMIWEB
    15 Apr 2026
    Share Share
    Forlong Bio To Unveil FL115, & FL116, Data At 2026 AACR Meeting
    Forlong Bio To Unveil FL115, & FL116, Data At 2026 AACR Meeting

    17 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-17/forlong-biotechology-to-present-preclinical-data-from-fl115-a-novel-interleukin-15-il-15-superago

    PHARMIWEB
    17 Mar 2026
    Share Share
    Forlong Bio Activates FL115 Phase Ib/II With Anti-PD-1 Antibody
    Forlong Bio Activates FL115 Phase Ib/II With Anti-PD-1 Antibody

    07 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-07/forlong-biotechology-announced-activation-of-phase-ibii-study-of-fl115-il-15-superagonist-in-comb

    PHARMIWEB
    07 Jan 2026
    Share Share
    Forlong Biotechology to Present Clinical Data from FL115
    Forlong Biotechology to Present Clinical Data from FL115

    30 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251030436980/en/Forlong-Biotechology-to-Present-Clinical-Data-from-FL115-a-novel-interleukin-15-IL-15-superagonist-in-Late-breaking-Session-at-40th-SITC-Annual-Meeting

    BUSINESSWIRE
    30 Oct 2025
    Share Share
    Forlong Dosed First Patient in Phase 2 Clinical Trial of FL115
    Forlong Dosed First Patient in Phase 2 Clinical Trial of FL115

    30 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251030585675/en/Forlong-Dosed-First-Patient-in-Phase-2-Clinical-Trial-of-FL115-a-novel-interleukin-15-IL-15-superagonist-for-nonmuscle-invasive-bladder-cancer-NMIBC

    BUSINESSWIRE
    30 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search